PASCAR Roadmap on Hypertension

PASCAR Roadmap on Hypertension

262 CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 4, July/August 2017 AFRICA PASCAR Roadmap on Hypertension Roadmap to achieve 25% hypertension control in Africa by 2025 Anastase Dzudie, Brian Rayner, Dike Ojji, Aletta E Schutte, Marc Twagirumukiza, Albertino Damasceno, Seringe Abdou Ba, Abdoul Kane, Euloge Kramoh, Jean Baptiste Anzouan Kacou, Basden Onwubere, Ruth Cornick, Karen Sliwa, Benedict Anisiuba, Ana Olga Mocumbi, Elijah Ogola, Mohamed Awad, George Nel, Harun Otieno, Ali Ibrahim Toure, Samuel Kingue, Andre Pascal Kengne, Pablo Perel, Alma Adler, Neil Poulter, Bongani Mayosi, on behalf of the PASCAR task force on hypertension Department of Internal Medicine, Yaoundé Faculty of Institut cardiologique d’Abidjan, Abidjan, Cote d’Ivoire Medicine and Biomedical Sciences, Yaoundé, Cameroon Euloge Kramoh, MD Anastase Dzudie, MD, PhD, FESC, [email protected] Jean Baptiste Anzouan Kacou, MD Samuel Kingue, MD, PhD Department of Medicine, University of Nigeria Teaching Department of Medicine, University of Cape Town, Cape Hospital, Enugu, Nigeria Town, South Africa Basden Onwubere, MD Anastase Dzudie, MD, PhD, FESC Knowledge Translation Unit, University of Cape Town Lung Karen Sliwa, MD, PhD Institute and Department of Medicine, University of Cape Bongani Mayosi, MD Town, Cape Town, South Africa Hatter Institute for Cardiovascular Research in Africa, Ruth Cornick, MD Department of Medicine, Groote Schuur Hospital, Department of Medicine, University of Nigeria Teaching University of Cape Town, Cape Town, South Africa Hospital, Enugu, Nigeria Anastase Dzudie, MD, PhD, FESC Benedict Anisiuba, MD Karen Sliwa, MD, PhD National Health Institute, Mozambique and University Division of Nephrology and Hypertension, Department of Eduardo Mondlane, Maputo, Mozambique Medicine, Groote Schuur Hospital and University of Cape Ana Olga Mocumbi, MD Town, Cape Town, South Africa Department of Clinical Medicine and Therapeutics, Brian Rayner, MD University of Nairobi, Kenya Department of Medicine, Faculty of Health Sciences, Elijah Ogola, MD University of Abuja; Cardiology Unit, Department Division of Cardiology, University of Khartoum, Khartoum, of Medicine, University of Abuja Teaching Hospital, Sudan Gwagwalada, Abuja, Nigeria Mohamed Awad, MD Dike Ojji, MD Pan-African Society of Cardiology (PASCAR), Cape Town, Hypertension in Africa Research Team (HART); MRC Unit South Africa for Hypertension and Cardiovascular Disease, North-West George Nel University, Potchefstroom, South Africa Section of Cardiology, Department of Medicine, Aga Khan Aletta E Schutte, MD University Hospital, Nairobi, Kenya College of Medicine and Health Sciences, University Harun Otieno, MD of Rwanda, Kigali, Rwanda and African Society of Division of Cardiology, University of Khartoum, Sudan Hypertension (AfSoH) Initiative, Heymans Institute of Ali Ibrahim Toure, MD Pharmacology, Ghent University, Ghent, Belgium Marc Twagirumukiza, MD Medical Research Council, Cape Town, South Africa Andre Pascal Kengne, MD Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique Science Advisory Unit, World Heart Federation, Geneva, Albertino Damasceno, MD Switzerland and London School of Hygiene and Tropical Medicine, London, UK Le Dantec University Teaching Hospital, Dakar, Senegal Pablo Perel, MD Seringe Abdou Ba, MD Alma Adler, MD Service de cardiologie, Hôpital Général de Grand Yolf, International Centre for Circulatory Health, Imperial Dakar, Senegal College, London, UK Abdoul Kane, MD Neil Poulter, MD AFRICA CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 4, July/August 2017 263 preventing and controlling non-communicable diseases (NCDs). Abstract Target six of the action plan aims to achieve a 25% relative Background and aim: The Pan-African Society of Cardiology reduction in the prevalence of raised blood pressure or to (PASCAR) has identified hypertension as the highest area contain this by 2020, according to national circumstances. of priority for action to reduce heart disease and stroke State and government heads in the UN Political Declaration on the continent. The aim of this PASCAR roadmap on are committed to preventing and controlling NCDs through hypertension was to develop practical guidance on how to the establishment and strengthening of multi-sectoral national implement strategies that translate existing knowledge into policies and plans. effective action and improve detection, treatment and control The Pan-African Society of Cardiology (PASCAR) met of hypertension and cardiovascular health in sub-Saharan several times to identify key actions for a hypertension roadmap Africa (SSA) by the year 2025. on the continent. The PASCAR coalition identified several Methods: Development of this roadmap started with the roadblocks hampering the control of hypertension on the creation of a consortium of experts with leadership skills in continent, which exist at government/health-system, physician hypertension. In 2014, experts in different fields, including and patient levels and include the following. physicians and non-physicians, were invited to join. Via face- to-face meetings and teleconferences, the consortium made a situation analysis, set a goal, identified roadblocks and solu- Government- and health system-related roadblocks tions to the management of hypertension and customised the World Heart Federation roadmap to Africa. • lack of established policies for controlling hypertension Results: Hypertension is a major crisis on the continent but • poor political willingness to implement policies on NCDs very few randomised, controlled trials have been conducted • poor universal health insurance coverage, leading to out-of- on its management. Also, only 25.8% of the countries have pocket payment by most patients, which leads to poor access developed or adopted guidelines for the management of and adherence to treatment hypertension. Other major roadblocks are either govern- • lack of policies on antihypertensive medication procurement ment and health-system related or healthcare professional or and distribution, resulting in stock shortages patient related. The PASCAR hypertension task force identi- • lack of ad hoc screening and proper referral systems for fied a 10-point action plan to be implemented by African patients identified at routine screening ministries of health to achieve 25% control of hypertension • inability of governments to effectively work with the private in Africa by 2025. sector, non-governmental organisations (NGOs) and academ- Conclusions: Hypertension affects millions of people in SSA ia in a coordinated plan to tackle the burden of hypertension. and if left untreated, is a major cause of heart disease and stroke. Very few SSA countries have a clear hypertension policy. This PASCAR roadmap identifies practical and effec- Healthcare professional-related roadblocks tive solutions that would improve detection, treatment and • lack of appropriate evidence-based guidelines for healthcare control of hypertension on the continent and could be imple- professionals in individual countries mented as is or adapted to specific national settings. • hypertension treatment guidelines are poorly implemented because of a lack of continuing medical education Keywords: hypertension, roadmap, Africa, prevalence, control, • a dearth of healthcare professionals (physicians, nurses and blood pressure, action trained health workers) at primary care level with very low physician/patient ratio Submitted 26/5/17, accepted 12/8/17 • lack of quality and affordable antihypertension medications. Cardiovasc J Afr 2017; 28: 261–272 www.cvja.co.za Co-published in Global Heart Patient-related roadblocks DOI: 10.5830/CVJA-2017-040 • poor awareness about hypertension and its consequences • poor adherence to drug therapy because of limited access to medication Executive summary • difficulty in changing lifestyles, and false health beliefs that The Word Health Organisation (WHO) estimated that the number hypertension is curable, due to poor patient education. of people affected by hypertension is highest in Africa, at about 46% of adults aged 25 years and older, compared to 35 to 40% elsewhere in the world. Many hypertensive Africans are unaware PASCAR 10-point action plan of their status, and are rarely treated or poorly controlled, making The PASCAR hypertension task force identified a 10-point them at highest risk for stroke, and heart and renal disease. action plan, to be implemented by African ministries of health to African Union member states at the 2004 Addis Ababa achieve 25% control of hypertension in Africa by 2025. meeting described hypertension as one of the continent’s greatest 1. All NCD national programmes should additionally contain health challenges after HIV/AIDS. An urgency was recognised to a plan for the detection of hypertension. develop and share best practices, including affordable and effective 2. Allocate appropriate funding and resources for the early community-based programmes to screen and treat hypertension. detection, efficient treatment and control of hypertension. The WHO’s 2013–2020 global action plan calls upon the 3. Create or adopt simple and practical clinical evidence-based United Nations (UN) member states to take immediate action in hypertension management guidelines. 264 CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 4, July/August 2017 AFRICA 4. Annually monitor and report the detection, treatment and above which treatments have been shown to reduce clinical control rates of hypertension, with a clear target of improve-

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    12 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us